Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Cg Oncology Inc (NASDAQ: CGON) was $20.48 for the day, up 0.34% from the previous closing price of $20.41. In other words, the price has increased by $0.34 from its previous closing price. On the day, 1.52 million shares were traded. CGON stock price reached its highest trading level at $21.2 during the session, while it also had its lowest trading level at $19.905.
Ratios:
Our analysis of CGON’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 35.30 and its Current Ratio is at 35.30. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on April 16, 2025, initiated with a Sector Perform rating and assigned the stock a target price of $23.
On October 24, 2024, UBS started tracking the stock assigning a Buy rating and target price of $60.UBS initiated its Buy rating on October 24, 2024, with a $60 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 17 ’25 when POST LEONARD E sold 1,000 shares for $28.00 per share. The transaction valued at 28,000 led to the insider holds 0 shares of the business.
LEONARD E POST bought 4,000 shares of CGON for $111,200 on Mar 17 ’25. On Feb 18 ’25, another insider, POST LEONARD E, who serves as the Director of the company, sold 1,000 shares for $28.61 each. As a result, the insider received 28,610 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGON now has a Market Capitalization of 1560921984 and an Enterprise Value of 819161216. For the stock, the TTM Price-to-Sale (P/S) ratio is 1369.23 while its Price-to-Book (P/B) ratio in mrq is 2.13. Its current Enterprise Value per Revenue stands at 719.193 whereas that against EBITDA is -7.146.
Stock Price History:
The Beta on a monthly basis for CGON is 1.34, which has changed by -0.43190014 over the last 52 weeks, in comparison to a change of 0.042615533 over the same period for the S&P500. Over the past 52 weeks, CGON has reached a high of $46.99, while it has fallen to a 52-week low of $14.80. The 50-Day Moving Average of the stock is -16.76%, while the 200-Day Moving Average is calculated to be -35.15%.
Shares Statistics:
CGON traded an average of 830.98K shares per day over the past three months and 1394840 shares per day over the past ten days. A total of 76.15M shares are outstanding, with a floating share count of 46.04M. Insiders hold about 39.60% of the company’s shares, while institutions hold 67.15% stake in the company. Shares short for CGON as of 1743379200 were 8048175 with a Short Ratio of 9.69, compared to 1740700800 on 6999756. Therefore, it implies a Short% of Shares Outstanding of 8048175 and a Short% of Float of 10.65.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
